the-year-in-review-top-articles-from-2022 Blog Related Topics 
Technology & Marketing Law Blog
JULY 12, 2022
I’m pleased to announce the 2022 edition (13th edition) of my Internet Law casebook, Internet Law: Cases & Materials. The book is available as a PDF at Gumroad for $10, a Kindle ebook for $9.99, a softcover version for $20, and (new this year!) Despite rampant inflation, these prices have stayed the same for years.
Velocity of Content
SEPTEMBER 21, 2022
As with my earlier post on the overall role of peer review in the scholarly and scientific publishing process, for Peer Review Week 2022 we are reposting this series and including some updated information on the topics we covered: An article in Nature Medicine suggests access to preprints might be good for patient outcomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IPilogue
JANUARY 14, 2022
This article features contributions from Ryan Wong (IP Osgoode & IP Innovation Clinic Alumnus), Sabrina Macklai (IPilogue Senior Editor), Tianchu Gao (IPilogue Writer), and Ashley Moniz (IPilogue Managing Editor). 2021 was an exciting year for the IPilogue. 2021 was an exciting year for the IPilogue. David Vaver.
The IP Law Blog
AUGUST 4, 2022
It’s been referred to as one of the top copyright cases to watch this year. which established the “server test,” which essentially stands for the proposition that a website does not legally “display” a copyrighted image if that website does not communicate the work to viewers from a copy of that image stored on its own servers.
Technology & Marketing Law Blog
MAY 11, 2022
At the bottom of this post, I’ve included the text as passed by the Minnesota House] The bill fits the “protect-the-kids” narrative that politicians champion during election years, but it’s counterproductive towards that purported goal. What The Bill Says. generated content.”
43(B)log
FEBRUARY 17, 2022
11, 2022) This is the main liability opinion. Elysium prepared its own GRAS notification for NR but did not submit to the FDA, and its GRAS assessment for PT wasn’t reviewed by an independent panel. In re: Elysium Health-ChromaDex Litigation, No. 17-cv-7394 (LJL) (S.D.N.Y. Both parties get partial wins/losses on summary judgment.
Kluwer Copyright Blog
DECEMBER 4, 2023
To ensure you don’t miss out on interesting IP law developments reported on our other IP blogs, we will, on a regular basis, provide you with an overview of the most-read posts from each of our IP law blogs. Here are the most popular posts over the past few months. This has led to increasing calls for transparency requirements.
Expert insights. Personalized for you.
139 
Let's personalize your content